Nursing role in the treatment of major electrocardiographic alterations: acute coronary syndrome
Section: CUIDADOS DE ENFERMERÍA EN LAS ALTERACIONES ELECTROCARDIOGRÁFICAS
Authors
Juan Carlos Rubio Sevilla
Position
Enfermero en el Centro de Salud de Torrijos. Toledo.Enfermero Especialista en Enfermería Geriátrica.Especialista en Investigación en salud. Universidad de Castilla La Mancha (UCLM).Experto en Dirección de organizaciones sanitarias. Universidad Carlos III de Madrid (UCIII).
Contact address
Juan Carlos Rubio Sevilla. Comité Editorial Enfermería en Cardiología. Casa del Corazón Ntra.Sra. de Guadalupe, 5-7. 28028 Madrid
Abstract
Thirty years ago, nitroglycerin, acetylsalicylic acid, morphic chloride and heparin were hardly available for the treatment of acute coronary syndrome (ACS), and infarction was classified depending on the presence or absence of pathological Q wave. In recent years, the variability in the clinical practice of patients with ACS has decreased in Spain and around the world. There have been many changes, such as in the expansion of the therapeutic arsenal, new combined drugs (polytablets) and health products. There have also been other changes in scientific evidence by virtue of multiple studies, structural and operational changes, improvements in prehospital care, etc. The higher complexity of these patients requires a multidisciplinary approach, with coordination among care levels and a protocolization of health care from the first contact to chronic follow-up.
The cardiology nurse has the responsibility to implement this knowledge in her clinical practice so as to allow the diagnosis, prognosis and survival of this type of patient to go on improving. Care provided must be guided by safety within the importance that the time factor has in these patients.
Keywords:
myocardial infarction; acute coronary syndrome; angioplasty; anticoagulants; fibrinolysis; reperfusionsecondary prevention
Versión en Español
Título:
Artículo completo no disponible en este idioma / Full article is not available in this language
Bibliography
1. Documento consolidado BOE-A-2015-14028. [acceso el 30 de noviembre de 2018].
Disponible en: https://www.boe.es/buscar/pdf/2015/BOE-A-2015-14028-consolidado.pdf
2. SCApp: App para el manejo del síndrome coronario agudo. [acceso el 30 de noviembre de 2018]. Disponible en: https://secardiologia.es/multimedia/apps/6942-scapp
3. Roffi M, et al. Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST. Rev Esp Cardiol. 2015;68(12):1125.
Disponible en: http://www.revespcardiol.org/es/pdf/90445376/S300/
4. Ibáñez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018; 39:119–177.
5. F. Alfonso, et al. Comentarios a la guía ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevación del segmento ST. Rev Esp Cardiol. 2017;70(12):1039-1045.
Disponible en: http://www.revespcardiol.org/es/pdf/90461837/S300/
6. Nikolaou NI, et al. European Resuscitation Council Guidelines for Resuscitation 2015 Section 8. Initial management of acute coronary syndromes. Resuscitation, Volume 95, 264 ““ 277. Disponible en:
http://www.resuscitationjournal.com/article/S0300-9572(15)00342-1/pdf
7. O´Connor RE, Al Ali AS, Brady WJ, Ghaemmaqhami CA et al. Part 9: Acute coronary sndromes. 2015 American Heart Association Guidelines Update for cardiopulmonary resuscitation and emergency doi cardiovascular care. Circulation 2015. Disponible en:
circ.ahajournals.org/content/132/18_suppl_2/S483.full.pdf+html
8. Marzal D, López-Sendón JL, Roldán I. Proceso asistencial simplificado del síndrome coronario agudo. Actualización 2017. Madrid: Sociedad Española de Cardiología; 2017. Disponible en: https://secardiologia.es/images/publicaciones/libros/proceso-asistencial-simpificado-sca-2017.pdf
9. Hamm CW, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2999-3054.
10. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2012;33:1635-701.
11. Chow CK, Jolly S, Rao-Melacini P, Fox KA, Anand SS, Yusuf S, et al. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation. 2010;121:750-8.
12. Fox K, Langrish J. Estratificación del riesgo en los síndromes coronarios agudos. Rev Esp Cardiol. 2010;63:629-32 - Vol. 63. Disponible en:
http://www.revespcardiol.org/es/pdf/13150997/S300/
13. Silber S, et al. Guías de Práctica Clínica sobre intervencionismo coronario percutáneo. Rev Esp Cardiol. 2005;58:679-728. Disponible en:
http://www.revespcardiol.org/es/pdf/13076420/S300/
14. Barrios V, et al. Utilidad de un policomprimido cardiovascular en el tratamiento de pacientes en prevención secundaria en España: un estudio de coste-efectividad. Rev Esp Cardiol. 2017;70(1):42–49. Disponible en:
http://www.revespcardiol.org/es/pdf/90460482/S300/
